The document discusses the use of diffusion-weighted imaging (DWI) in abdominal and pelvic MRI. It finds that DWI improves lesion detection sensitivity, especially for metastases, and can help characterize lesions when gadolinium contrast is contraindicated. DWI provides quantitative tissue analysis without contrast and may help longitudinally assess tumor response to therapy. Given its merits and availability on most MRI systems, DWI should be considered a routine sequence in abdominal MRI protocols, particularly when contrast cannot be used.